Kidney drug trial pulled before it even started

NCT ID NCT06120673

Terminated Disease control Sponsor: The University of Queensland Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This was a planned study to compare a newer drug, obinutuzumab, against a standard treatment (steroids plus cyclophosphamide) for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The goal was to see which treatment worked better and had fewer side effects. However, the trial was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Obinutuzumab
What this could lead to: If successful, obinutuzumab could offer a new treatment option for primary membranous nephropathy with fewer side effects than current therapies.
What could go wrong: The trial was withdrawn before enrolling any participants, so no data is available. It is unclear if obinutuzumab is effective or safe for this condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY MEMBRANOUS NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic membranous glomerulonephritis membranous glomerulonephritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY MEMBRANOUS NEPHROPATHY

Contacts and locations

Locations

Bundaberg Hospital

Bundaberg, Queensland, Australia
Cairns Hospital

Cairns, Queensland, Australia
Canberra Hospital

Garran, Australian Capital Territory, Australia
Fiona Stanley Hospital

Murdoch, Western Australia, Australia
Logan Hospital

Logan City, Queensland, Australia
Mackay Base Hospital

Mackay, Queensland, Australia
Mater Hospital

South Brisbane, Queensland, Australia
Princess Alexandra Hospital

Woolloongabba, Queensland, Australia
Rockhampton Hospital

Rockhampton, Queensland, Australia
Royal Brisbane and Women's Hospital

Brisbane, Queensland, Australia
Royal Hobart Hospital

Hobart, Tasmania, Australia
Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia
Sunshine Coast University Hospital

Birtinya, Queensland, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.